🔎 Trials Near Me

Почетна › Рак дојке › Florida

Kliničke studije za Рак дојке u državi Florida

144 studija za Рак дојке traži učesnike na lokacijama u državi Florida.

Gradovi u državi Florida

Zvanični tekst studije (na engleskom)

Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation

  • Mayo Clinic - Jacksonville, Jacksonville
  • Miami Cancer Institute, Miami
  • Miami Cancer Institute Plantation, Plantation
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 13. 11. 2026. · NCT05696626

A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With Early-stage and Advanced HR+ Breast Cancer

  • Regis Clinical Research, Miami
  • Cancer Centers of Florida, Ocoee
Тражи се учесникФаза 1
Узраст од 18 до 55 · Жене · Ажурирано 12. 11. 2026. · NCT07310420

S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity

  • Moffitt Cancer Center, Tampa
  • Cleveland Clinic-Weston, Weston
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT03418961

Trial of 225Ac-DOTATATE (RYZ101) in Subjects With ER+, HER2-negative Unresectable or Metastatic Breast Cancer Expressing SSTRs.

  • Research Facility, Jacksonville
Тражи се учесникФаза 1/2
Сви узрасти · Оба пола · Ажурирано 12. 11. 2026. · NCT06590857

A Phase 1/1b Study of PRT13722 in Participants With Advanced HR+/HER2- Breast Cancer

  • Florida Clinical Trials Group, Tamarac
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT07905001

A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer

  • Hematology - Oncology Associates of the Treasure Coast, Port Saint Lucie
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 10. 11. 2026. · NCT06827236

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

  • AdventHealth Medical Group Oncology and Hematology at Altamonte ( Site 0044), Altamonte Springs
  • Florida Cancer Specialists - South ( Site 7004), Fort Myers
  • Bioresearch Partner ( Site 0072), Hialeah
  • и још 2
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 10. 11. 2026. · NCT06966700

ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer

  • Mayo Clinic, Jacksonville
  • Sylvester Comprehensive Cancer Center, Miami
  • Moffitt Cancer Center, Tampa
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 9. 11. 2026. · NCT07007559

A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors

  • SCRI Florida Cancer Specialists - Sarasota, Sarasota
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT07029399

Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

  • Helios CR Inc, Lakeland
  • H. Lee Moffitt Cancer Center and Research Institute, Tampa
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT06324357

A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials

  • University of Florida, Gainesville
  • Mayo Clinic in Florida, Jacksonville
  • University of Miami, Miami
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
Узраст од 18 до 100 · Оба пола · Ажурирано 5. 11. 2026. · NCT05655494

Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer

  • Baptist MD Anderson, Jacksonville
  • Mayo Clinic Florida, Jacksonville
  • Jupiter Medical Cancer, Jupiter
  • и још 2
Тражи се учесник
Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT07214532

Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration

  • Mayo Clinic, Jacksonville
  • Moffitt Cancer Center, Tampa
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT05315700

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

  • AdventHealth, Altamonte Springs
  • Florida Cancer Specialists-South, Fort Myers
  • Cancer Care Centers of Brevard, Inc, Palm Bay
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT06982521

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

  • AdventHealth Altamonte Springs, Altamonte Springs
  • Clermont Oncology Center, Clermont
  • BRCR Global - Coral Springs, Coral Springs
  • и још 6
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07174336

A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer

  • Cancer Specialists of North Florida - Jacksonville, Jacksonville
  • Tallahassee Memorial HealthCare, Tallahassee
  • Moffitt Cancer Center-McKinley Campus, Tampa
  • и још 1
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT06790693

E-Mindfulness Approaches for Living After Breast Cancer

  • UM Sylvester Comprehensive Cancer Center at Aventura, Aventura
  • UM Sylvester Comprehensive Cancer Center at Coral Gables, Coral Gables
  • UM Sylvester Comprehensive Cancer Center at Coral Springs, Coral Springs
  • и још 11
Тражи се учесникФаза 3
Узраст од 18 до 50 · Оба пола · Ажурирано 4. 11. 2026. · NCT06748222

A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer

  • AdventHealth Altamonte Springs, Altamonte Springs
  • Mayo Clinic in Florida, Jacksonville
Тражи се учесникФаза 2
Узраст 18 и старији · Жене · Ажурирано 4. 11. 2026. · NCT07287098

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • Mount Sinai Comprehensive Cancer Center at Aventura, Aventura
  • Schulze Family Foundation Cancer Clinic - Bonita Health Center, Bonita Springs
  • Morton Plant Hospital, Clearwater
  • и још 11
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
Узраст од 40 до 75 · Оба пола · Ажурирано 4. 11. 2026. · NCT05334069

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

  • USOR Florida Cancer Specialists South, Fort Myers
  • USOR Florida Cancer Specialists North, St. Petersburg
  • USOR Florida Cancer Specialists East, West Palm Beach
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT05579366

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

  • Morton Plant Hospital, Clearwater
  • South Florida Baptist Hospital, Plant City
  • Saint Anthony's Hospital Cancer Care Center, St. Petersburg
  • и још 2
Тражи се учесникОпсервациона студија
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT06418204

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

  • Moffitt, Tampa
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07213791

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

  • Moffitt, Tampa
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07114601

A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

  • Florida Cancer Specialists & Research Institute - Fort Myers Cancer Center - Gladiolus, Fort Myers
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT06760819

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

  • AdventHealth Altamonte, Altamonte Springs
  • Mount Sinai Comprehensive Cancer Center at Aventura, Aventura
  • UM Sylvester Comprehensive Cancer Center at Aventura, Aventura
  • и још 37
Тражи се учесникФаза 3
Узраст од 18 до 60 · Жене · Ажурирано 4. 11. 2026. · NCT05879926

A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus Ribociclib Plus Fulvestrant in Participants With Advanced Breast Cancer

  • Cancer Specialists of North Florida, Jacksonville
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT07405801

A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)

  • AdventHealth Medical Group Oncology and Hematology at Altamonte ( Site 0024), Altamonte Springs
  • Comprehensive Hematology Oncology ( Site 0060), St. Petersburg
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT07060807

A Study of JNJ-101684362 (HLD-0117) in Patients With Metastatic Breast Cancer

  • Florida Cancer Specialists, Sarasota
Тражи се учесникФаза 1
Узраст 18 и старији · Жене · Ажурирано 3. 11. 2026. · NCT07524855

To Study the Effect of Inavolisib in Combination With Fulvestrant in Participants With Breast Cancer

  • Cancer Specialists of North Florida, Jacksonville
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT07368998

A Phase 1 Study of IM-1617 in Participants With Advanced Cancer

  • Florida Cancer Specialists & Research Institute - Sarasota Cattlemen, Sarasota
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT07578571

The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study

  • Miami Cancer Institute, Miami
  • Miami Cancer Institute, Plantation
Тражи се учесникФаза 3
Узраст 60 и старији · Оба пола · Ажурирано 2. 11. 2026. · NCT06377852

ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer

  • Florida Cancer Specialists, Fort Myers
  • Cancer Care Centers of Brevard, Inc, Palm Bay
  • Sacred Heart Medical Oncology Group, Pensacola
  • и још 1
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 30. 10. 2026. · NCT07173751

Tumor Treating Fields for the Treatment of Leptomeningeal Metastases of the Spine in Patients With Breast or Lung Cancer

  • Mayo Clinic in Florida, Jacksonville
Тражи се учесник
Узраст 18 и старији · Оба пола · Ажурирано 30. 10. 2026. · NCT05746325

A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer

  • Holy Cross Hospital, Fort Lauderdale
  • The Oncology Institute, Lakeland
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 29. 10. 2026. · NCT07102381

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

  • Florida Cancer Specialists - Lake Nona, Orlando
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 28. 10. 2026. · NCT07109726

EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)

  • AdventHealth East Altamonte Oncology and Hematology, Altamonte
  • Mount Sinai Medical - Comprehensive Cancer Center, Miami Beach
  • Orlando Health Cancer Institute - Downtown Orlando, Orlando
  • и још 2
Тражи се учесникОпсервациона студија
Узраст 18 и старији · Оба пола · Ажурирано 27. 10. 2026. · NCT06401421

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

  • AdventHealth Medical Group Oncology Research at Celebration, Kissimmee
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 26. 10. 2026. · NCT06172478

A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer

  • Sylvester Comprehensive Cancer Center, Miami
  • Moffitt Cancer Center, Tampa
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 26. 10. 2026. · NCT07100106

BRain-AVOidant Proton Craniospinal Irradiation for Leptomeningeal Metastases From Solid Tumor Malignancies

  • University of Miami, Miami
Тражи се учесник
Узраст 18 и старији · Оба пола · Ажурирано 23. 10. 2026. · NCT07789912

Phase 1 Study of STRO-006 in Adults With Refractory Solid Tumors That Are Recurrent or Metastatic

  • SCRI at Florida Cancer Specialists, Orlando
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 23. 10. 2026. · NCT07807345

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.